Literature DB >> 24036565

Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods.

Elizabeth A Cromwell1, Jeremiah Ngondi, Gideon Gatpan, Steven Becknell, Lucia Kur, Deborah McFarland, Jonathan D King, Paul M Emerson.   

Abstract

Trachoma control includes mass drug administration (MDA) with antibiotics targeting coverage of at least 80%. Coverage is traditionally calculated by dividing doses distributed by population estimate, which is unreliable. We compared a verifiable coverage assessment method against self-reported participation and the traditional calculation, and examined factors associated with MDA participation in Akobo County, Southern Sudan. During MDA, recipients were marked with indelible ink and followed-up using a two-stage household survey: 25 clusters from three districts, and 10 households per cluster. All household members were enumerated; asked about self-reported participation and observed for indelible marks. Household heads were interviewed to assess factors associated with MDA. Overall 11 419 treatments were given and 1358 residents from 247 households surveyed. By traditional methods MDA coverage was 20.9% (95% CI: 20.6-21.3); 61.5% (95 % CI: 49.4-73.6) by self-reporting; and 37.5% (95% CI: 25.1%-49.9%) from observed ink marks. Controlling for other factors, presence of a health worker (OR 2.3, 95% CI: 1.5-3.6); head of household knowledge of azithromycin (OR 1.6, 95% CI: 1.5-3.1); and head of household advance notice of MDA (OR 34.9, 18.1-66.3) were independent predictors of participation. Cluster randomised surveys can estimate MDA coverage better than the traditional method and implementation of indelible marking merits investigation.

Entities:  

Year:  2009        PMID: 24036565     DOI: 10.1016/j.inhe.2009.09.002

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  11 in total

1.  Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali.

Authors:  Sanoussi Bamani; Jonathan D King; Mamadou Dembele; Famolo Coulibaly; Dieudonne Sankara; Yaya Kamissoko; Jim Ting; Lisa A Rotondo; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

2.  Mass treatment with azithromycin for trachoma control: participation clusters in households.

Authors:  Elizabeth N Ssemanda; Beatriz Munoz; Emma M Harding-Esch; Tansy Edwards; Harran Mkocha; Robin L Bailey; Ansumana Sillah; Dianne Stare; David C W Mabey; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

3.  Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.

Authors:  Emily Griswold; Abel Eigege; Cephas Ityonzughul; Emmanuel Emukah; Emmanuel S Miri; Ifeoma Anagbogu; Yisa A Saka; Saliu Kadiri; Solomon Adelamo; Paul Ugbadamu; Clement Ikogho; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 3.707

4.  Mass drug administration for trachoma: how long is not long enough?

Authors:  Violeta Jimenez; Huub C Gelderblom; Rebecca Mann Flueckiger; Paul M Emerson; Danny Haddad
Journal:  PLoS Negl Trop Dis       Date:  2015-03-23

5.  Measuring and modelling the effects of systematic non-adherence to mass drug administration.

Authors:  Louise Dyson; Wilma A Stolk; Sam H Farrell; T Déirdre Hollingsworth
Journal:  Epidemics       Date:  2017-03       Impact factor: 4.396

6.  Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.

Authors:  Timothy P Finn; Joshua O Yukich; Adam Bennett; Travis R Porter; Christopher Lungu; Busiku Hamainza; Elizabeth Chizema Kawesha; Ruben O Conner; Kafula Silumbe; Richard W Steketee; John M Miller; Joseph Keating; Thomas P Eisele
Journal:  Am J Trop Med Hyg       Date:  2020-08       Impact factor: 2.345

7.  Monitoring of mass distribution interventions for trachoma in Plateau State, Nigeria.

Authors:  Elizabeth A Cromwell; Jonathan D King; Scott McPherson; Falam N Jip; Amy E Patterson; Aryc W Mosher; Darin S Evans; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

8.  Intestinal parasite prevalence in an area of ethiopia after implementing the SAFE strategy, enhanced outreach services, and health extension program.

Authors:  Jonathan D King; Tekola Endeshaw; Elisabeth Escher; Genetu Alemtaye; Sileabatt Melaku; Woyneshet Gelaye; Abebe Worku; Mitku Adugna; Berhanu Melak; Tesfaye Teferi; Mulat Zerihun; Demelash Gesese; Zerihun Tadesse; Aryc W Mosher; Peter Odermatt; Jürg Utzinger; Hanspeter Marti; Jeremiah Ngondi; Donald R Hopkins; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06

9.  Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.

Authors:  Tansy Edwards; Elizabeth Allen; Emma M Harding-Esch; John Hart; Sarah E Burr; Martin J Holland; Ansumana Sillah; Sheila K West; David Mabey; Robin Bailey
Journal:  PLoS Negl Trop Dis       Date:  2014-08-28

10.  Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.

Authors:  Tigist Astale; Eshetu Sata; Mulat Zerihun; Andrew W Nute; Aisha E P Stewart; Demelash Gessese; Gedefaw Ayenew; Berhanu Melak; Melsew Chanyalew; Zerihun Tadesse; E Kelly Callahan; Scott D Nash
Journal:  PLoS Negl Trop Dis       Date:  2018-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.